SPT Labtech Limited Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2001

Location

Hertfordshire UK

Primary Industry

Biotechnology

About

Based in Melbourne, England, abd founded in 2001, SPT Labtech Limited, formerly known as TTP Labtech Limited, offers data driven solutions for life sciences applications such as drug discovery, molecular biology and genomics and structural biology to eliminate drug-discovery bottlenecks. In June 2022, EQT agreed to acquire SPT Labtech Limited from Battery Ventures for GBP 650 million. As of January 2024, David Newble is the Chief Executive Officer (CEO) of the company. SPT Labtech Limited has accelerated its research and development activities by working together, applying expertise, and utilizing technical solutions. GlaxoSmithKline plc, Dart NeuroScience LLC, and Abcam plc are some of the notable partners. The company's product portfolio includes offerings such as Dragonfly Discovery, Dragonfly Crystal, Mosquito HV Genomics, Mosquito LV Genomics, Mosquito Xtal3, Mosquito (LCP, HV, LV, X1, and Crystal), Chameleon, Arktic XC, Arktic, comPOUND, and Lab2Lab, which benefit scientists, service teams, and budget holders. SPT Labtech utilized pneumatic technology to create a pharmaceutical research and development instrument capable of sorting, storing, and transporting samples. Additionally, the organization uses positive displacement pipetting for liquid handling. Additionally, SPT Labtech offers an automated online analysis solution that incorporates Nanoscale chemistry to improve drug discovery research. The company also provides technical support and instrument relocation services, which include pre-inspection, decommissioning, transportation, reinstallation, and testing of instruments. SPT Labtech provides application support services such as annual preventive maintenance, phone and email assistance, remote access support, application software updates, user training, and performance optimization sessions.

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Diagnostic, Medical & Imaging Laboratories

Website

www.sptlabtech.com

Company Stage

Mature

Total Amount Raised

Subscriber access only

Deals

Deals Type
Secondary Buyout
Add-on
Add-on
Buyout

Deal Status	Target (s)	Deal Date
Completed	SPT Labtech Limited	22 Jun 2022
Completed	BioMicroLab, Inc.	15 Feb 2021
Completed	Apricot Designs, Inc.	20 Jan 2021
Completed	SPT Labtech Limited	27 Sep 2018

Displaying 1-4 of 4

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.